标题
WIP1 phosphatase as pharmacological target in cancer therapy
作者
关键词
Cancer, Phosphatase, Checkpoint, DNA damage response, Inhibitor, p53
出版物
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 95, Issue 6, Pages 589-599
出版商
Springer Nature
发表日期
2017-04-25
DOI
10.1007/s00109-017-1536-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Wip 1 inhibits intestinal inflammation in inflammatory bowel disease
- (2016) Qi Zhang et al. CELLULAR IMMUNOLOGY
- Truncating and missensePPM1Dmutations in early-onset and/or familial/hereditary prostate cancer patients
- (2016) Marta Cardoso et al. GENES CHROMOSOMES & CANCER
- Chemical Inhibition of Wild-Type p53-Induced Phosphatase 1 (WIP1/PPM1D) by GSK2830371 Potentiates the Sensitivity to MDM2 Inhibitors in a p53-Dependent Manner
- (2016) A. Esfandiari et al. MOLECULAR CANCER THERAPEUTICS
- MDM2 oligomers: antagonizers of the guardian of the genome
- (2016) P L Leslie et al. ONCOGENE
- Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy
- (2016) V Clausse et al. Cell Death & Disease
- TP53 mutations, expression and interaction networks in human cancers
- (2016) Xiaosheng Wang et al. Oncotarget
- MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53
- (2016) Chinami Makii et al. Oncotarget
- The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma
- (2016) Kensuke Kojima et al. Oncotarget
- Somatic Mosaic Mutations inPPM1DandTP53in the Blood of Women With Ovarian Carcinoma
- (2016) Elizabeth M. Swisher et al. JAMA Oncology
- Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis
- (2016) Zhenghu Chen et al. Scientific Reports
- Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation
- (2015) Sari Ogasawara et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Phosphatase Wip1 controls antigen-independent B-cell development in a p53-dependent manner
- (2015) W. Yi et al. BLOOD
- Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients
- (2015) A Zajkowicz et al. BRITISH JOURNAL OF CANCER
- Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines
- (2015) Derek Edwardson et al. CURRENT DRUG METABOLISM
- The same, only different - DNA damage checkpoints and their reversal throughout the cell cycle
- (2015) I. A. Shaltiel et al. JOURNAL OF CELL SCIENCE
- CRISPR-Cas9–based target validation for p53-reactivating model compounds
- (2015) Michael Wanzel et al. Nature Chemical Biology
- Cancer whole-genome sequencing: present and future
- (2015) H Nakagawa et al. ONCOGENE
- Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
- (2015) Luc Rochette et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Wip1 deficiency impairs haematopoietic stem cell function via p53 and mTORC1 pathways
- (2015) Zhiyang Chen et al. Nature Communications
- Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma
- (2015) Lindi Chen et al. Oncotarget
- WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma
- (2015) Mark Richter et al. PLoS One
- Regulation of p53: a collaboration between Mdm2 and Mdmx
- (2015) Dongsheng Pei et al. Oncotarget
- Inhibition of C-terminal truncated PPM1D enhances the effect of doxorubicin on cell viability in human colorectal carcinoma cell line
- (2014) Yuuki Kozakai et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Wild-type p53-induced phosphatase 1 (Wip1) forestalls cellular premature senescence at physiological oxygen levels by regulating DNA damage response signaling during DNA replication
- (2014) Hiroyasu Sakai et al. CELL CYCLE
- Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase
- (2014) Erik Müllers et al. CELL CYCLE
- Preclinical Optimization of MDM2 Antagonist Scheduling for Cancer Treatment by Using a Model-Based Approach
- (2014) B. Higgins et al. CLINICAL CANCER RESEARCH
- Efficient Reactivation of p53 in Cancer Cells by a Dual MdmX/Mdm2 Inhibitor
- (2014) Lingyun Qin et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Transient Activation of p53 in G2 Phase Is Sufficient to Induce Senescence
- (2014) Lenno Krenning et al. MOLECULAR CELL
- Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction
- (2014) Aidan G Gilmartin et al. Nature Chemical Biology
- Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas
- (2014) Liwei Zhang et al. NATURE GENETICS
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Distinct phosphatases antagonize the p53 response in different phases of the cell cycle
- (2014) I. A. Shaltiel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wip1 Controls Global Heterochromatin Silencing via ATM/BRCA1-Dependent DNA Methylation
- (2013) Doria Filipponi et al. CANCER CELL
- Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis
- (2013) Libor Macurek et al. CELL CYCLE
- Genetic variants and mutations ofPPM1Dcontrol the response to DNA damage
- (2013) Crissy Dudgeon et al. CELL CYCLE
- Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
- (2013) Petra Kleiblova et al. JOURNAL OF CELL BIOLOGY
- Off-target response of a Wip1 chemical inhibitor in skin keratinocytes
- (2013) Ji-Seon Lee et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development
- (2013) Qingjie Ding et al. JOURNAL OF MEDICINAL CHEMISTRY
- WIP1, a Homeostatic Regulator of the DNA Damage Response, Is Targeted by HIPK2 for Phosphorylation and Degradation
- (2013) Dong Wook Choi et al. MOLECULAR CELL
- Synergistic and tunable human gene activation by combinations of synthetic transcription factors
- (2013) Pablo Perez-Pinera et al. NATURE METHODS
- Wip1 suppresses apoptotic cell death through direct dephosphorylation of BAX in response to γ-radiation
- (2013) J-Y Song et al. Cell Death & Disease
- Towards structure-based protein drug design
- (2012) Changsheng Zhang et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Over-expression of Wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas
- (2012) Chaohui Liang et al. BRAIN RESEARCH
- Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xLratio
- (2012) Anastasia R. Goloudina et al. CELL CYCLE
- Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
- (2012) J. Ross Chapman et al. MOLECULAR CELL
- Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
- (2012) Elise Ruark et al. NATURE
- Optimization of a Cyclic Peptide Inhibitor of Ser/Thr Phosphatase PPM1D (Wip1)
- (2011) Ryo Hayashi et al. BIOCHEMISTRY
- A small molecule inhibitor of p53-inducible protein phosphatase PPM1D
- (2011) Hiroaki Yagi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival
- (2011) Naoyuki Satoh et al. CANCER SCIENCE
- Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
- (2011) S. E. Polo et al. GENES & DEVELOPMENT
- The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation
- (2011) A Y Ali et al. ONCOGENE
- Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents
- (2011) A. R. Goloudina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1
- (2011) Melanie Blasius et al. GENOME BIOLOGY
- Downregulation of Wip-1 phosphatase expression in MCF-7 breast cancer cells enhances doxorubicin-induced apoptosis through p53-mediated transcriptional activation of Bax
- (2010) Weihong Kong et al. CANCER BIOLOGY & THERAPY
- Wip1 Directly Dephosphorylates -H2AX and Attenuates the DNA Damage Response
- (2010) H. Cha et al. CANCER RESEARCH
- The Wip1 phosphatase and Mdm2: Cracking the "Wip" on p53 stability
- (2010) Xiongbin Lu et al. CELL CYCLE
- Weak p53 permits senescence during cell cycle arrest
- (2010) Olga V. Leontieva et al. CELL CYCLE
- The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair
- (2010) Thuy-Ai Nguyen et al. DNA REPAIR
- Wild-type p53-induced Phosphatase 1 Dephosphorylates Histone Variant γ-H2AX and Suppresses DNA Double Strand Break Repair
- (2010) Sung-Hwan Moon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Wip1 phosphatase is associated with chromatin and dephosphorylates γH2AX to promote checkpoint inhibition
- (2010) L Macůrek et al. ONCOGENE
- Phosphorylation and Degradation of MdmX Is Inhibited by Wip1 Phosphatase in the DNA Damage Response
- (2009) X. Zhang et al. CANCER RESEARCH
- Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
- (2009) R. Natrajan et al. CLINICAL CANCER RESEARCH
- PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas
- (2009) D. S.P. Tan et al. CLINICAL CANCER RESEARCH
- Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression
- (2009) Arne Lindqvist et al. EMBO JOURNAL
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- WIP1 phosphatase is a negative regulator of NF-κB signalling
- (2009) Joanne Chew et al. NATURE CELL BIOLOGY
- Cell fate decision mediated by p53 pulses
- (2009) X.-P. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Senescent Growth Arrest in Mesenchymal Stem Cells Is Bypassed by Wip1-Mediated Downregulation of Intrinsic Stress Signaling Pathways
- (2009) Ji-Seon Lee et al. STEM CELLS
- WIP1 phosphatase at the crossroads of cancer and aging
- (2009) Xavier Le Guezennec et al. TRENDS IN BIOCHEMICAL SCIENCES
- The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways
- (2008) Xiongbin Lu et al. CANCER AND METASTASIS REVIEWS
- PPM1D430, a Novel Alternative Splicing Variant of the Human PPM1D, can Dephosphorylate p53 and Exhibits Specific Tissue Expression
- (2008) Y. Chuman et al. JOURNAL OF BIOCHEMISTRY
- Arsenic Trioxide Augments Chk2/p53-mediated Apoptosis by Inhibiting Oncogenic Wip1 Phosphatase
- (2008) Akinori Yoda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of the Active Site and a Unique Uncompetitive Inhibitor of the PPM1-Type Protein Phosphatase PPM1D
- (2008) Yoshiro Chuman et al. PROTEIN AND PEPTIDE LETTERS
- An Oncogene-Induced DNA Damage Model for Cancer Development
- (2008) T. D. Halazonetis et al. SCIENCE
- A Small Molecular Scaffold for Selective Inhibition of Wip1 Phosphatase
- (2007) Jeong Bang et al. ChemMedChem
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started